First Nebraska Trust Co Acquires 4,077 Shares of UnitedHealth Group Incorporated $UNH

First Nebraska Trust Co bought a new stake in UnitedHealth Group Incorporated (NYSE:UNH) in the 3rd quarter, Holdings Channel.com reports. The fund bought 4,077 shares of the healthcare conglomerate’s stock, valued at approximately $1,497,000.

A number of other institutional investors and hedge funds also recently made changes to their positions in the company. Corient Private Wealth LP acquired a new stake in UnitedHealth Group in the second quarter worth about $245,516,000. Legal & General Group Plc bought a new position in shares of UnitedHealth Group in the 2nd quarter valued at about $2,444,928,000. Jupiter Topco LLC bought a new position in shares of UnitedHealth Group in the 2nd quarter valued at about $2,019,844,000. BlackRock Inc. grew its position in shares of UnitedHealth Group by 4.6% during the 2nd quarter. BlackRock Inc. now owns 76,863,061 shares of the healthcare conglomerate’s stock worth $31,946,594,000 after buying an additional 3,395,530 shares during the period. Finally, Canada Pension Plan Investment Board bought a new stake in shares of UnitedHealth Group during the second quarter worth approximately $971,757,000. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group News Roundup

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: Earnings and outlook are key tailwinds. UnitedHealth’s quarterly EPS and revenue beat analysts’ estimates, and the company raised its 2026 profit outlook. Those results helped drive an approximately 11% share gain over the month through October 30. UnitedHealth Just Gained 11% in a Month: Take Profits, or Buy More?
• Positive Sentiment: Buying and value-oriented endorsements provide support. ETFs recorded net purchases of UnitedHealth shares, including $35 million in buying on October 29. BetterInvesting Magazine also named UNH its “Undervalued Stock,” though such selections are not a guarantee of future performance. UnitedHealth Group Draws ETF Buying BetterInvesting Magazine Update
• Neutral Sentiment: Optum Insight’s AI investment is a longer-term opportunity with execution risk. UnitedHealth is expanding AI tools to improve efficiency and claims processing, but rising costs mean the spending still needs to translate into profit growth. Will UNH’s Optum Insight Spending Translate Into Profit Growth?
• Negative Sentiment: Political scrutiny could weigh on sentiment. Senator Elizabeth Warren criticized the Trump administration’s approval of UnitedHealth’s $3.3 billion Amedisys acquisition, arguing the deal increases the company’s power over costs and patient care. The comments renew attention to potential regulatory and political risks. Elizabeth Warren Criticizes UnitedHealth’s Amedisys Deal

Wall Street Analyst Weigh In

A number of equities research analysts recently commented on UNH shares. Sanford C. Bernstein dropped their price objective on UnitedHealth Group from $512.00 to $500.00 and set an “outperform” rating for the company in a report on Wednesday, October 14th. Argus boosted their target price on UnitedHealth Group from $400.00 to $470.00 and gave the stock a “buy” rating in a research report on Monday, July 20th. New Street Research set a $402.00 price target on UnitedHealth Group in a research note on Friday, October 9th. Barclays cut their price target on shares of UnitedHealth Group from $441.00 to $440.00 and set an “overweight” rating on the stock in a research report on Wednesday, October 14th. Finally, Raymond James Financial restated an “outperform” rating and set a $450.00 price objective on shares of UnitedHealth Group in a report on Thursday, October 15th. Twenty analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $463.93.

UnitedHealth Group Stock Up 0.7%

Shares of UnitedHealth Group stock opened at $403.10 on Wednesday. UnitedHealth Group Incorporated has a 1 year low of $255.96 and a 1 year high of $461.62. The business has a 50-day moving average of $390.47 and a two-hundred day moving average of $363.08. The company has a market capitalization of $361.81 billion, a P/E ratio of 23.02, a price-to-earnings-growth ratio of 1.45 and a beta of 0.51. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.74 and a quick ratio of 0.78.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, October 13th. The healthcare conglomerate reported $4.69 EPS for the quarter, topping analysts’ consensus estimates of $4.14 by $0.55. UnitedHealth Group had a return on equity of 17.95% and a net margin of 3.53%. The company had revenue of $112.72 billion for the quarter, compared to analyst estimates of $111.31 billion. During the same quarter last year, the firm posted $2.59 earnings per share. UnitedHealth Group’s revenue was down .4% compared to the same quarter last year. UnitedHealth Group has set its FY 2026 guidance at 20.500- EPS. As a group, equities analysts predict that UnitedHealth Group Incorporated will post 20.61 EPS for the current year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, September 22nd. Shareholders of record on Monday, September 14th were paid a $2.32 dividend. The ex-dividend date of this dividend was Monday, September 14th. This represents a $9.28 dividend on an annualized basis and a yield of 2.3%. UnitedHealth Group’s payout ratio is presently 53.00%.

Insider Buying and Selling at UnitedHealth Group

In other news, CEO Patrick Conway sold 1,169 shares of the stock in a transaction on Friday, August 21st. The shares were sold at an average price of $390.00, for a total transaction of $455,910.00. Following the completion of the sale, the chief executive officer owned 15,328 shares of the company’s stock, valued at $5,977,920. This represents a 7.09% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. 0.19% of the stock is owned by company insiders.

About UnitedHealth Group

UnitedHealth Group Incorporated (NYSE: UNH) is a diversified health care company that provides health insurance coverage, health care services, pharmacy services and health technology. Its businesses serve individuals, employers, government programs, health care providers and other organizations, primarily in the United States.

The company operates through two principal businesses. UnitedHealthcare offers health benefit plans and related services for employers, individuals, families and government-sponsored programs, including Medicare and Medicaid.